Below, we share the stories of three projects at IBAB, each of which began with a societal gap area and was built, end to end, into an experiment designed to answer it through genomics; a philosophy of advancing training and research in tandem, at a time when the field itself was evolving fast.

NGS liberated developing countries from their dependence on the West for defining and pursuing their own research priorities. For the first time, the ability to generate and analyze genomic data was becoming accessible enough that countries could build biological resources around questions of national importance. For me, one such question emerged very early: Could genomics help India address protein malnutrition, control malaria, find hidden cause for rare genetic disorders within families?

But How? Where to begin?

Bioinformatics is arguably one of the fields most naturally prepared for modern AI because the field has spent decades converting biology into large, structured, machine-readable datasets. In many ways, AI arrived in biology after bioinformatics had already built the infrastructure that AI needed.

UNIX, Command-line and pipelines

For most of its history, biology was an observational and experimental science. Scientists studied organisms, cells, tissues, and molecules by looking at them, manipulating them, and recording what happened. The information generated by these experiments was often descriptive and, for the most part, remained closely tied to the laboratory in which it was produced. The transformation of biology into a data-driven science began when biological information could be measured at scale, represented digitally, stored systematically, and analyzed computationally.

Microarrays transformed gene expression into numerical matrices containing measurements for thousands of genes simultaneously. The arrival of high-throughput technologies accelerated this transformation dramatically. The next-generation sequencing revolution made it possible to generate millions and eventually billions of short DNA fragments in a single experiment enabling measurement of genome-scale gene expression, variations, epigenetic changes and proteomics across diverse biological contexts. Structural biology produced increasingly large repositories of experimentally determined molecular structures. Every technological advance added another layer to the digital representation of biology.

Yet generating digital data was only the beginning. The data had to be organized, interpreted, and connected to biological meaning. This was the problem that gave rise to modern bioinformatics.

Early bioinformatics developed algorithms that translated biological questions into computational procedures. Sequence alignment determined how two or more sequences could be compared. Dynamic programming provided systematic solutions to alignment problems. Genome assembly reconstructed long DNA sequences from millions of fragments. Gene-prediction programs such as GENSCAN used probabilistic models to recognize genes within genomic DNA. Multiple sequence alignment transformed collections of related sequences into representations of evolutionary conservation. Public databases allowed researchers to search previously generated information rather than repeat experiments that had already been performed elsewhere.

Traditional bioinformatics generally required humans to tell the computer what to look for. A programmer defined the states, rules, scoring systems, features, or statistical models, and the computer searched for the best solution. Whether assembling a genome, aligning sequences, predicting genes, or identifying conserved residues, the underlying biological assumptions were largely specified in advance.

Modern artificial intelligence changes this relationship.

Instead of explicitly defining every feature that may be biologically important, AI can learn patterns from enormous collections of biological data. A model can encounter millions of protein sequences and learn relationships among amino acids without being explicitly programmed with the rules of protein evolution. It can process vast quantities of genomic sequence and learn sequence patterns associated with genes, regulatory elements, or other biological features. It can learn representations that connect sequence to structure, structure to function, and genetic variation to phenotype.

The distinction is profound. Classical bioinformatics primarily encoded human knowledge into algorithms; modern AI increasingly allows algorithms to extract knowledge from the data themselves.

This chapter follows that transition—from biological information being digitized, to biological data being computationally analyzed, and finally to biological knowledge being learned by machines. It provides the bridge between the algorithmic era of bioinformatics and the emerging era of AI-driven biology.

The proteome is the complete set of proteins produced by a biological system at a particular time and under a particular condition. Unlike the genome, which is relatively stable, the proteome is highly dynamic. It changes with cell type, developmental stage, environmental conditions, disease, nutrition, and other physiological states. This dynamic nature makes proteins especially valuable for understanding what a cell is doing.

Proteins are the primary functional molecules of the cell. They act as enzymes, receptors, transporters, structural components, signaling molecules, and regulators of gene expression. Although the genome provides the blueprint for producing these molecules, the presence of a gene does not necessarily indicate that its corresponding protein is produced, in what quantity, or in what functional state. Proteomics therefore provides a layer of biological information that lies closer to phenotype than the genome or transcriptome.

The systematic study of proteins began long before the word proteomics was coined. Individual proteins were purified, characterized, and sequenced using biochemical methods throughout the twentieth century. The development of mass spectrometry, together with advances in protein separation, peptide chemistry, chromatography, and computational analysis, transformed this field. Instead of studying one protein at a time, it became possible to identify and quantify thousands of proteins in a biological sample simultaneously.

A typical modern proteomics experiment begins with extraction of proteins from a biological sample such as a cell, tissue, blood, plant, or microbial community. The proteins are usually digested into peptides, commonly using the enzyme trypsin. The resulting peptides are separated by liquid chromatography and introduced into a mass spectrometer. The instrument measures the mass-to-charge ratio (m/z) of peptide ions and, through tandem mass spectrometry, generates fragmentation patterns that can be used to identify the peptides and, consequently, the proteins from which they originated.

The computational component is central to modern proteomics. Observed peptide spectra can be compared with theoretical spectra generated from protein databases derived from genome or transcriptome sequences. Matching peptides provide evidence for the presence of proteins. The number or intensity of peptide signals can then be used to estimate relative or absolute protein abundance, depending on the experimental method.

An important advantage of proteomics is that it can reveal biological changes that cannot be inferred from DNA sequence alone. Two organisms may have nearly identical genomes but produce very different amounts of proteins under different environmental conditions. Even within the same cell, proteins can undergo post-translational modifications (PTMs) such as phosphorylation, acetylation, glycosylation, and ubiquitination. These modifications can alter protein activity, localization, stability, or interactions without changing the underlying DNA sequence.

Proteomics can therefore be viewed as another form of high-dimensional biological measurement. Just as RNA-seq converts gene expression into a gene-by-sample matrix, proteomics can generate a protein-by-sample matrix in which each sample is represented as a vector of protein abundances. These vectors can subsequently be compared using correlation, distance measures, PCA, clustering, machine learning, and other computational approaches.

One of the ambitious goals of whole-metagenome sequencing (WMGS) is to obtain full genome assemblies of hundreds or thousands of novel unculturable microbes. It is challenging because the sequencing data contain DNA from hundreds or thousands of organisms with vastly different abundances. Highly abundant organisms generate large numbers of reads and can dominate the dataset, while low-abundance organisms may have insufficient coverage for reliable assembly. In addition, closely related organisms can contribute highly similar sequences, making it difficult to assign reads and assembled contigs to the correct organism.

These challenges have led to the development of a variety of metagenome assembly strategies, broadly including alignment-based (reference-guided) and composition-based (de novo) approaches. The choice of strategy depends on the availability of reference genomes, the complexity of the microbial community, and the abundance and divergence of the organisms present.

One of the ambitious goals of whole-metagenome sequencing (WMGS) is to obtain full genome assemblies of hundreds or thousands of novel unculturable microbes. It is challenging because the sequencing data contain DNA from hundreds or thousands of organisms with vastly different abundances. Highly abundant organisms generate large numbers of reads and can dominate the dataset, while low-abundance organisms may have insufficient coverage for reliable assembly. In addition, closely related organisms can contribute highly similar sequences, making it difficult to assign reads and assembled contigs to the correct organism.

These challenges have led to the development of a variety of metagenome assembly strategies, broadly including alignment-based (reference-guided) and composition-based (de novo) approaches. The choice of strategy depends on the availability of reference genomes, the complexity of the microbial community, and the abundance and divergence of the organisms present.

A particularly important transition is therefore occurring in microbial taxonomy. 16S rRNA moved microbial identification from culture-dependent phenotyping to sequence-based classification; whole-genome sequencing is now moving taxonomy from a single-marker system toward genome-wide phylogeny.

Prokaryotes are ubiquitous and form a fundamental component of the biosphere, contributing substantially to global biomass and playing essential roles in carbon, nitrogen, and other biogeochemical cycles. The microbial world is extraordinarily diverse with only a small fraction of the estimated millions to billions of microbial species have been formally described, and an even smaller fraction has been cultured and experimentally characterized. Microorganisms live in intimate association with plants and animals and can profoundly influence their metabolism, development, immunity, and health. The collective genomes of microorganisms associated with a host are therefore sometimes referred to as its “second genome.”

The composition and abundance of microbial communities vary dramatically with their environment. A teaspoon of soil, for example, can contain an enormous diversity of microorganisms, often including thousands of bacterial and archaeal taxa, with highly uneven abundances. The human gut contains a much smaller but still remarkably diverse community, comprising hundreds to more than a thousand bacterial species depending on the individual and the criteria used to define a species. Plant roots are particularly rich microbial habitats because they interact directly with soil and release nutrients that support specialized microbial communities. Marine environments are similarly diverse with even a milliliter of seawater containing hundreds of thousands to millions of microbial cells representing thousands of different taxa.

Before the advent of next-generation sequencing (NGS), microbiology depended heavily on isolating microorganisms and growing them in culture. Individual organisms could then be studied for their biochemical properties, or their genomes could be sequenced. This approach, however, was fundamentally limited by cultivability. Many microorganisms cannot readily be grown under standard laboratory conditions. The first complete bacterial genome to be sequenced was that of Haemophilus influenzae, published in 1995. For many years thereafter, genome sequencing remained largely an organism-by-organism exercise and was constrained by the cost and labor required for Sanger sequencing.

The enormous microbial diversity present in natural environments far exceeds the diversity that can be cultured in the laboratory. This created a major blind spot in traditional microbiology leading to organisms that could not be isolated could not easily be studied. Genome sequencing of cultured bacteria nevertheless revealed extensive diversity in gene content and provided a foundation for assigning functions to conserved genes. Many genes retain significant homology across bacterial species, particularly at the protein level. However, because of the degeneracy of the genetic code, nucleotide sequences can diverge considerably while encoding similar or even identical proteins. Consequently, DNA-level homology can be insufficient for designing universal PCR primers for a gene family.

One solution is to target genomic regions that are sufficiently conserved across diverse microbial groups. Ribosomal RNA (rRNA) genes are particularly valuable because ribosomes are essential for protein synthesis and are present in all cellular organisms. Several regions of rRNA genes are highly conserved, while other regions evolve sufficiently rapidly allowing to distinguish between related organisms. This combination of conserved and variable regions makes rRNA genes excellent molecular markers for microbial identification and community profiling.

The comparison of genomes within a species and/or across different species has played a pivotal role in modern genomic research. Broadly, comparative genomics can be viewed at two levels. The first is a genome-wide comparison of basic features, such as genome size, chromosome number, GC content, gene density, number of coding sequences (CDS), and repetitive DNA. The second is a high-resolution comparison of the DNA sequences themselves, allowing individual genes, exons, regulatory elements, structural variants, and other genomic features to be examined in detail.

High-resolution comparative genomics is particularly powerful because evolutionary conservation provides an important clue to biological function. DNA sequences that remain conserved across related organisms are more likely to be functionally important, whereas rapidly diverging regions may be under weaker functional constraint. Comparison of related genomes can therefore help identify protein-coding genes, exons, regulatory elements, conserved non-coding regions, and other functional elements, even when these elements are difficult to recognize from a single genome alone. Conversely, comparison can also reveal lineage-specific sequences, gene losses, duplications, and other evolutionary changes.

A simple and intuitive method of genome comparison is a dot plot, in which two chromosomes or genomic sequences are compared by plotting regions of sequence similarity against their genomic coordinates. A continuous diagonal indicates that the sequences occur in the same linear order, whereas breaks, inversions, or displaced diagonal segments can reveal rearrangements, insertions, deletions, and inversions.

For comparison of multiple genomes, tools such as MAUVE can identify locally collinear blocks and reveal large-scale rearrangements, inversions, and other structural differences. Such analyses are particularly useful for examining synteny, the conservation of the relative order of genes or other genomic elements between chromosomes or species.

Comparative genomics is largely computational, but interpretation remains essential. A computationally detected similarity does not automatically imply identical biological function, and differences in genome assembly quality, annotation, repetitive DNA, and evolutionary distance can strongly influence the results. Thus, visualization tools such as dot plots and genome browsers, together with sequence alignment and phylogenetic analysis, are often used to interpret the observed similarities and differences.

One of the striking observations from comparative genomics is that organisms often retain many of the same genes while their order and chromosomal locations can change substantially during evolution. Orthologous genes that occur together on human chromosome 1, for example, may be distributed across several chromosomes in another species because of chromosome rearrangements, translocations, inversions, and fusion or fission events. Comparative genomics therefore provides a powerful way to reconstruct the evolutionary history of chromosomes while simultaneously identifying conserved genomic elements that are likely to be functionally important.

Epigenomics examines heritable or persistent changes in gene regulation that do not require changes in the underlying DNA sequence. Major epigenetic features include DNA methylation, histone modifications, chromatin accessibility, nucleosome positioning, and three-dimensional chromatin interactions. Because each feature requires a different experimental assay, the computational analysis also differs.

The early 1990s marked the era of expressed sequence tag (EST) sequencing, an ingenious strategy aimed at identifying human genes without waiting for the complete human genome sequence. Instead of sequencing the entire genome, researchers sequenced short portions of cDNA derived from expressed transcripts. These ESTs provided sequence tags for expressed genes and rapidly expanded the catalogue of human genes.

The success of the EST approach laid the foundation for microarray technology, which enabled genome-wide measurement of gene expression across different tissues, developmental stages, disease states, and experimental conditions. Microarrays became one of the dominant technologies for transcriptome profiling for more than a decade.

RNA sequencing (RNA-seq) has largely replaced microarrays for transcriptome analysis because sequencing provides a more direct and comprehensive measurement of RNA abundance. Microarrays are fundamentally hybridization-based detection technologies: a transcript can be detected only if a corresponding probe is already represented on the array. Consequently, transcripts that are novel, poorly annotated, highly divergent, or expressed as previously unknown isoforms may be missed.

Microarrays also have limitations in their quantitative range. Fluorescence intensity is used as a proxy for transcript abundance, but the relationship between transcript concentration and measured fluorescence is not perfectly linear over the entire dynamic range. At high transcript concentrations, probe spots can become saturated, placing an upper limit on the measurable signal. At the other end of the spectrum, weak signals can be difficult to distinguish from background fluorescence. Because genes can differ by several orders of magnitude in expression level, capturing both very highly and very weakly expressed transcripts accurately in a single hybridization experiment is challenging.

RNA-seq addresses many of these limitations by counting sequenced reads derived from RNA molecules rather than measuring hybridization intensity. It does not require a predefined probe for every transcript and can therefore detect novel transcripts, alternative splice isoforms, allele-specific expression, and previously unannotated genes, provided sufficient sequencing depth and appropriate analysis methods are used. Its digital nature also provides a substantially broader dynamic range than microarray fluorescence measurements.

Thus, the progression from EST sequencing → microarrays → RNA-seq represents a broader evolution in transcriptomics: from identifying individual expressed sequences, to measuring predefined transcripts simultaneously, and finally to directly sampling and quantifying the transcriptome through high-throughput sequencing.

Resequencing refers to sequencing the genomes of multiple individuals from a species for the purpose of identifying genetic variation by comparing their sequences with an already assembled reference genome of that species. Unlike de novo genome assembly, resequencing does not require reconstructing the entire genome from scratch. Instead, sequencing reads are aligned to the reference genome, and differences such as SNPs, small insertions and deletions (indels), structural variants, and copy-number variations can be identified.

The availability of a high-quality reference genome dramatically reduces the computational and sequencing effort required to study genetic diversity across individuals and populations. Resequencing has therefore become one of the most powerful applications of NGS, particularly for species in which a reference genome is already available.

Because biological function is ultimately what makes a genomic sequence useful, a major objective of genome projects is to identify transcriptional units, determine their exon–intron structures, and assign functions to the proteins and non-coding RNAs encoded by the genome. Genome annotation has therefore evolved from simple ORF finding into a multi-layered process that integrates ab initio prediction, homology, transcript evidence, protein evidence, comparative genomics, and functional databases.

In early genome projects, gene identification relied heavily on de novo gene prediction, often using Generalized Hidden Markov Models (GHMMs). These programs infer genes from intrinsic properties of genomic DNA, including coding potential, codon usage, splice-site signals, and the expected organization of exons and introns. Although predictions from these methods are imperfect, they remain valuable, particularly when little or no experimental information is available for a newly sequenced organism.

Modern annotation pipelines increasingly combine several independent sources of evidence. RNA-seq and full-length transcript sequencing can provide direct evidence for transcription and exon–intron boundaries, while long-read transcript technologies such as PacBio Iso-Seq and Oxford Nanopore cDNA/direct-RNA sequencing can resolve complete transcript structures and alternative isoforms. Protein homology provides another powerful layer of evidence, allowing predicted genes to be compared with experimentally characterized proteins from related organisms. Comparative genomics can further identify conserved coding regions that are difficult to recognize from sequence composition alone.

Annotation has also expanded beyond protein-coding genes. Modern genome projects routinely identify and annotate non-coding RNAs, regulatory elements, repetitive sequences, transposable elements, pseudogenes, and structural features of chromosomes. For complex eukaryotic genomes, annotation may therefore involve separate tracks for genes, transcripts, promoters, enhancers, ncRNAs, repeats, and other functional elements.

Several automated annotation platforms are widely used. RAST (Rapid Annotation using Subsystem Technology) has been particularly influential for bacterial and archaeal genomes, where its subsystem-based approach provides rapid identification and functional assignment of genes. Other widely used approaches include Prokka and Bakta for prokaryotic genomes and BRAKER, MAKER, and Funannotate for eukaryotic genomes. Large genome resources such as Ensembl and NCBI RefSeq combine computational annotation with extensive comparative and experimental evidence.

Despite these advances, manual curation remains essential for high-confidence annotation. Ensembl distinguishes automatic annotation as the genome-wide determination of transcripts from manual curation, in which individual gene models are reviewed and corrected on a case-by-case basis. UniProtKB/Swiss-Prot remains a classic example of high-quality manually curated protein annotation, in contrast to automatically annotated entries in TrEMBL. Curators can resolve errors in exon boundaries, distinguish closely related paralogs, identify alternative transcripts, and assign functions based on experimental evidence that automated pipelines may miss.

The central principle has therefore shifted from “predicting genes” to “integrating evidence.” A high-quality annotation is no longer defined simply by the number of predicted genes, but by how convincingly independent lines of evidence support each gene model and its proposed biological function.

For assembled genomes to become biologically useful resources, it is essential to identify and annotate the regions that encode proteins and other functional elements. It is important to note that only about 1.5% of the three-billion-base human genome consists of protein-coding sequences, while the majority comprises regulatory regions, introns, repetitive elements, non-coding RNAs, and other genomic features. In contrast, genomes of prokaryotes are much more compact, with a substantially higher proportion of coding DNA. Protein-coding genes in bacteria and archaea are often densely packed, with relatively short intergenic regions, and in some cases, genes may even overlap.

Therefore, genome annotation, the process of identifying genes, predicting their structures, and assigning potential functions, is a critical step after assembly. While the quality of the assembly determines the accuracy with which genomic regions can be reconstructed, annotation transforms the raw sequence into a functional genome resource that can be used for comparative genomics, evolutionary studies, and understanding the genetic basis of biological traits.

Imagine a machine that could walk along the 2-meter-long DNA molecules packed inside the nucleus of every cell and report the identity of every base it encounters. There would be little need for genome assembly and much of this chapter would become unnecessary.

Sequencing machines can accurately read only a limited stretch of DNA before the signal becomes too noisy. If a machine can reliably read 100–200 bases before it begins to “blabber,” the result is a short sequencing read, such as the approximately 150-base reads commonly generated by Illumina platforms.

Now imagine deploying a billion Lilliputians, each landing at a random location on the nuclear DNA from many cells and walking as far as it can while accurately reporting the bases it encounters. We would obtain a billion short reads, each representing a small fragment of the genome. If these reads were distributed randomly across the genome, many would overlap with one another. These overlaps provide the clues needed to reconstruct progressively longer stretches of DNA, called contigs.

This is the fundamental challenge of genome assembly: reconstructing a long DNA sequence from millions or billions of short, overlapping observations. The quality of an assembly is not simply an all-or-none measure. A perfect telomere-to-telomere (T2T) assembly is the ultimate goal of assembling genomes of any organism, but obtaining such an assembly can require substantially more data and sophisticated technologies. The human genome draft published in 2001 contained thousands of gaps, yet it was enormously valuable and transformed our ability to study genes, genomic variation, and the functional organization of the genome.

Thus, a genome assembly does not need to be perfect to be useful. An assembly that produces sufficiently long contigs and scaffolds with meaningful genomic context can already provide a powerful foundation for gene discovery, comparative genomics, variant analysis, and aiding many biological applications.

A genome is the complete genetic blueprint of an organism, and genomics is the study of the structure, function, organization, and evolution of entire genomes. In cellular organisms, the genome consists of deoxyribonucleic acid (DNA), whereas some viruses use ribonucleic acid (RNA) as their genetic material. Although the terms genome and are often used interchangeably, they represent distinct concepts. The genome encompasses all the hereditary information required to build, maintain, and reproduce an organism, whereas the genome sequence is simply the linear arrangement of nucleotide bases that encodes this information.

Like words and sentences in a language, DNA and RNA sequences consist of ordered strings of discrete nucleotide units. These nucleotide sequences form the fundamental genomic elements that collectively determine the structure, regulation, and function of living organisms.

The classical central dogma of molecular biology—DNA → RNA → Protein—was formulated largely from studies in bacteria and provides a partial description of the genetic program of complex eukaryotes. Subsequent large-scale investigations, including the exhaustive analysis of approximately 1% of the human genome by the ENCODE pilot project, revealed an unexpectedly rich landscape of functional genomic elements1. Although only about 1.5% of the human genome is translated to encodes proteins, genome-wide studies using technologies such as EST sequencing, tiling microarrays and RNA sequencing have demonstrated that a substantial fraction of the genome is transcribed. Many of these transcribed sequences function as regulatory RNAs that influence gene expression, chromatin organization, development, and disease.

For many years, non-protein-coding regions were dismissed as "junk DNA" or referred to as genomic "dark matter" because their biological functions were poorly understood. It is now evident that many of these regions contain functional elements, including promoters, enhancers, non-coding RNAs, cis-regulatory elements, and structural features that play essential roles in regulating gene expression and cellular function.

The ability to identify sequence variation within these genomic elements has transformed biology and medicine. Once variants associated with specific biological traits or diseases are identified, they can be exploited for diagnostics, therapeutics, crop improvement, and vector control. Furthermore, genome-editing technologies such as CRISPR-Cas systems now allow many of these elements to be modified directly, creating unprecedented opportunities for functional studies and precision genetic engineering.

This chapter introduces the major classes of genomic and epigenomic elements currently investigated using high-throughput technologies, including genes and transcripts, promoters, enhancers, non-coding RNAs, small interfering RNAs (siRNAs), cis-regulatory elements, single nucleotide polymorphisms (SNPs), structural variants, and epigenetic modifications to find causative genotype under a phenotype of interest.

Scaffolding the very long contigs generated from PacBio and Oxford Nanopore assemblies requires long-range information that extends far beyond the capabilities of conventional mate-pair libraries. While mate-pair sequencing can provide links across genomic distances of several kilobases, it is not practical for connecting contigs separated by hundreds of kilobases or millions of bases. To overcome this limitation, technologies originally developed to study chromosome organization have been adapted for genome assembly.

Together, Hi-C and optical mapping have transformed genome assembly by providing chromosome-scale scaffolding information, bridging the gap between long-read assembly and complete reference-quality genomes. These technologies have been particularly important in generating telomere-to-telomere and near-complete genome assemblies for complex organisms.

Single-molecule real-time (SMRT) sequencing, pioneered by Pacific Biosciences and complemented by Nanopore sequencing technologies, represents a major advance over short-read sequencing approaches. The key breakthrough was the elimination of the DNA amplification step, allowing individual DNA molecules to be sequenced directly and avoiding biases introduced during PCR amplification. This direct sequencing approach also enabled the generation of much longer reads, typically in the range of 10–20 kb and beyond, providing valuable long-range information for genome assembly, structural variant detection, and resolving repetitive regions.

However, early single-molecule sequencing technologies were associated with substantially higher error rates, approaching 10–15% compared with the approximately 99.9% base-level accuracy of Illumina short reads. These errors were largely random and could be eliminated by sequencing the same molecule multiple times and alimenting them by improved consensus algorithms. Recent advances, particularly high-fidelity (HiFi) sequencing from PacBio, have dramatically improved accuracy while retaining long-read capabilities, bridging the gap between the accuracy of short reads and the genomic resolution offered by long reads.

Frederick Sanger first developed methods for sequencing proteins in the 1950s, establishing the foundation for determining the primary structure of biological macromolecules47. However, following the landmark discovery of the DNA double-helical structure by Watson and Crick in 1953, the focus of molecular biology rapidly shifted toward developing technologies for sequencing DNA.

This transition was driven by several fundamental insights. First, the central dogma of molecular biology established that genetic information flows from DNA to RNA and ultimately to proteins, with messenger RNA acting as the intermediate carrier of information48. Therefore, understanding DNA sequences provided a direct view of the genetic blueprint underlying biological function.

Second, DNA emerged as a more attractive molecule for technological manipulation and sequencing. DNA is chemically more stable than proteins, can be amplified, copied, and manipulated using enzymatic approaches, and contains information that can be interpreted using a universal genetic code49. Importantly, the relationship between DNA and protein sequences is directional and asymmetric because of the degeneracy of the genetic code.

For example, a protein sequence cannot uniquely determine its corresponding DNA sequence because multiple codons can encode the same amino acid. For example, the short peptide sequence ALKRST can be encoded by approximately 6,912 different DNA sequences because several amino acids in this peptide have multiple synonymous codons. In contrast, once a DNA sequence is known, the encoded protein sequence can usually be predicted unambiguously, except for the presence of multiple possible reading frames in an unknown DNA segment.

This asymmetry made DNA sequencing a far more powerful approach for understanding biology. A single DNA sequence provides access not only to the encoded protein but also to regulatory regions, non-coding elements, and evolutionary information embedded within the genome.

“With close to gene-expression data from one million biological contexts in the public repositories, researchers can identify disease trends without ever having to enter a laboratory.” Monya Baker.

Although the excitement of NGS technologies and the promise of transcriptome sequencing to both detect and discover novel genes is becoming trendy, there is no disagreement on the usefulness of the millions of gene expression profiles from microarrays in public repositories in biomarker discovery. As rightly described by Monya Baker, perhaps, one can identify disease trends without entering a laboratory as demonstrated by researchers at Stanford.

The advent of next-generation sequencing (NGS) between 2005 and 2009 transformed biological research. Modern sequencing platforms can now generate terabytes of data in a single run, with experiments completed within hours to days depending on the technology. Equally transformative has been the dramatic reduction in sequencing costs, which has democratized genomics and created bioinformatics as a discipline under life sciences. Individual investigators can now sequence the genome or transcriptome of virtually any organism of interest—a capability that was once limited to large international consortia or well-funded research institutions.

As sequencing throughput increased exponentially, bioinformatics evolved from a specialized discipline into an indispensable component of modern biological research. New algorithms, software tools, databases, and analytical pipelines have continuously emerged to keep pace with the data deluge and the rapidly expanding range of applications. The speed of these developments has been both exciting and challenging, leaving educators, students, and researchers struggling to remain current in an ever-changing technological landscape.

NGS has also transformed scientific research in developing nations by reducing dependence on Western research priorities. However, old habit dies hard. The launch of GenomeIndia project mimicking the West in addressing genetic diversity across India is one such example. Also, although countries such as India can now address their own biological and societal challenges using NGS, including protein malnutrition, crop improvement, infectious diseases such as malaria, biodiversity conservation, and the characterization of human genetic variation arising from centuries of endogamy and/or cousin marriages; the challenge is in training the work force with a different mindset. Unfortunately, the pace of technological innovation has made it increasingly difficult for academic curricula and research laboratories to keep pace.

The book details a fifteen-year educational journey (2010–2025) of building and delivering India's earliest comprehensive next-generation sequencing (NGS) data analysis curriculum at the Institute of Bioinformatics and Applied Biotechnology (IBAB). During this period the curriculum was dynamically updated as the research programs at IBAB kept evolving to keep pace with emerging sequencing technologies, computational methods, and burgeoning applications. The curriculum was designed around experiential learning, where classroom instruction was tightly integrated with active research projects. Rather than treating bioinformatics as a rigid set of software utilities, the book focuses on aligning experimental design with appropriate computational pipelines, analyzing genomic variations, and highlighting the limitations of current analytical tools. Its core scope bridges the gap between fundamental molecular biology and high-throughput computational algorithms.